In India, the number of recorded COVID-19 infections has surpassed 24 million. 4,000 or more deaths were reported for the third consecutive day.
Since the pandemic began, the country has confirmed more than 12 million cases and over 167,000 deaths.
Is big pharma overcharging for drugs repurposed to treat Covid-10 patients.
An intranasal vacccine for COVID-19 is under development by Indian pharma company Bharat Biotech. It announced yesterday that a unique intranasal vacccine named 'CoroFlu' is under development.